Home › Post-COVID Conditions (Long COVID) › Texas › Houston
Post-COVID Conditions (Long COVID) clinical trials in Houston, TX
13 studies for Post-COVID Conditions (Long COVID) are looking for participants at sites in and around Houston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)
RecruitingPhase 3
- Houston Methodist Hospital ( Site 3800), Houston
- MD Anderson ( Site 3843), Houston
A Study of COVID-19 Vaccine(s) in Children and Adults
RecruitingPhase 3Healthy volunteers welcome
- DM Clinical Research-Cyfair, Houston
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
RecruitingPhase 3
- Cockrell Center for Advanced Therapeutics, Houston
- Houston Methodist - Transplant Center, Houston
- Houston Methodist Hospital, Houston
- and 4 more
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
RecruitingPhase 3
- Memorial Hermann Hospital TMC, Houston
- The University of Texas Health Science Center at Houston, Houston
- UT Physicians, Houston
- and 4 more
The Impact of COVID-19 on Pulmonary Procedures
RecruitingObservational studyHealthy volunteers welcome
- M D Anderson Cancer Center, Houston
Assessment of the Psychosocial Impact of the COVID-19 Pandemic on the MD Anderson Cancer Center Workforce
RecruitingObservational study
- M D Anderson Cancer Center, Houston
Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
RecruitingPhase 3
- Baylor College of Medicine, Houston
- MD Anderson, Houston
The Effect of COVID-19 Pandemic on Adolescent and Young Adult Cancer Patients and Survivors
RecruitingObservational study
- M D Anderson Cancer Center, Houston
Impact of COVID-19 Pandemic on Out-of-Pocket Costs, Lost Wages, and Unemployment in Patients With Breast Cancer Undergoing Breast Surgery
RecruitingObservational study
- M D Anderson Cancer Center, Houston
Well-Being and Health-Related Quality of Life in Melanoma Patients During COVID-19 Pandemic
RecruitingObservational study
- M D Anderson Cancer Center, Houston
Vale+Tú Salud: Corner-Based Trial to Test a Latino Day Laborer Program Adapted to Prevent COVID-19
Recruiting
- The University of Texas Health Science Center at Houston, Houston
EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease
RecruitingPhase 3
- Texas Children's Hospital, Houston
Clazakizumab vs. Placebo - COVID-19 Infection
RecruitingPhase 2
- Houston Methodist Hospital, Houston
About Post-COVID Conditions (Long COVID)
Anyone who had COVID-19 can have ongoing symptoms. Learn about post-COVID conditions (long COVID), including symptoms, diagnosis, treatments, and prevention.
More about Post-COVID Conditions (Long COVID) on MedlinePlus
Post-COVID Conditions (Long COVID) trials in other cities
- New York City, NY15 studies
- Boston, MA13 studies
- Baltimore, MD12 studies
- Chicago, IL11 studies
- Washington, DC10 studies
- San Francisco, CA8 studies
- Durham, NC8 studies
- Atlanta, GA8 studies
- San Diego, CA7 studies
- Los Angeles, CA6 studies
- Pittsburgh, PA6 studies
- Miami, FL6 studies
Other studies in Houston
- Non-Small Cell Lung Cancer145 studies
- Breast Cancer126 studies
- Cancer (all types)121 studies
- Metastatic Cancer104 studies
- Colorectal Cancer102 studies
- Ovarian Cancer89 studies
- Acute Myeloid Leukemia85 studies
- Lung Cancer78 studies
- Prostate Cancer76 studies
- Endometrial Cancer68 studies
- Pancreatic Cancer61 studies
- Melanoma59 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.